Sviluppo di un modello diagnostico basato su MicroRNA sierici per la diagnosi di endometriosi
article
OA: closed
CC0
AI-generated summary
A diagnostic model using serum microRNAs was developed with Random Forest analysis, achieving an AUC of 0.863 to discriminate between endometriosis and control groups.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
INTRODUCTION: Endometriosis (END) is a debilitating gynecological disorder. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. The discovery of non-invasive biomarkers is necessary to overcome the disadvantages of surgical practice. MicroRNAs (miRNAs) are a family of small non-coding RNAs that, thanks to their high stability in biologic fluids, can represent excellent biomarkers for END. The purpose of this study was to develop a diagnostic model based on serum miRNA to identify patients affected by END.METHODS: Serum samples were collected before surgery and total RNA was extracted from 400 uL of serum of 67 patients with END and 60 patients with benign gynecological non endometriotic pathology, used as controls (CNT). miRNA expression profiling was performed via TaqMan OpenArray technology. For the development of the diagnostic algorithm to discriminate between END and CNT, the ‘Random Forest’ method was used, along with “Recursive Forward Elimination.”RESULTS: To explore the discrimination ability between END and CNT, a Random Forest algorithm based on 18 miRNAs was developed. The diagnostic performance of this model was characterized by Area Under the Curve (AUC)=0.863, False Positve Rate (FPR)=0.227, False Negative Rate (FNR)=0.196, Specificity=0.773 and Sensitivity=0.804.DISCUSSION: Our study identified a diagnostic algorithm that shows good performance in discriminating between END and CNT, supporting the potential role of circulating miRNA as non-invasive biomarkers of END.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- Accurate diagnosis of endometriosis using serum microRNAs via openalex
- Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis via openalex
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives via openalex
- Biomarkers in endometriosis: challenges and opportunities via openalex
- Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Plasma Micro-RNA Expression via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Endometriosis Associated-miRNome Analysis of Blood Samples: A Prospective Study via openalex
- Functional MicroRNA Involved in Endometriosis via openalex
- Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction via openalex
- Identification of MicroRNAs as Potential Biomarkers in Ovarian Endometriosis via openalex
- MicroRNA and gynecological reproductive diseases via openalex
- Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility via openalex
- Multicenter evaluation of blood‐based biomarkers for the detection of endometriosis and adenomyosis: A prospective non‐interventional study via openalex
- Pathogenesis Based Diagnosis and Treatment of Endometriosis via openalex
- Plasma miRNAs as biomarkers for endometriosis via openalex
- Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Salivary MicroRNA Signature for Diagnosis of Endometriosis via openalex
- Serum miR-17, IL-4, and IL-6 levels for diagnosis of endometriosis via openalex
- Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons (Papio anubis) With Experimentally-Induced Disease via openalex
- Serum miRNA as a predictive biomarker for ovarian reserve after endometrioma-cystectomy via openalex
- Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy research via openalex
- The Role of miRNAs 340‐5p, 92a‐3p, and 381‐3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem‐Like Cell Study via openalex
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis via openalex
- W4403606596 via openalex
- W2070642899 via openalex
- W2102236934 via openalex
- W2114584570 via openalex
- W2324255546 via openalex
- W2744391314 via openalex
- W3134885188 via openalex
- W3202177173 via openalex
- W4206520695 via openalex
- W4220849519 via openalex
- W4280549665 via openalex
- W4295242484 via openalex
- W4297310843 via openalex
- W4309541611 via openalex
- W4365810998 via openalex
- W282221905 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK